Celiac Panel at Home: Finger-Prick Options, Normal Ranges, and What Your Results Mean

Medical lab testing image for Celiac Panel at Home: Finger-Prick Options, Normal Ranges, and What Your Results Mean

At a glance

  • Primary marker / tTG-IgA (tissue transglutaminase IgA)
  • tTG-IgA normal range / <4 U/mL (most CLIA labs; negative)
  • tTG-IgA weakly positive / 4 to 10 U/mL (requires EMA confirmation)
  • tTG-IgA strongly positive / >10 U/mL (high likelihood of celiac; biopsy needed)
  • EMA-IgA specificity / ~98 to 99% when positive
  • DGP-IgG utility / preferred marker when total IgA is <7 mg/dL (IgA deficiency)
  • Gluten-free diet before testing / invalidates results; patient must be on gluten for 6 to 8 weeks
  • At-home finger-prick sensitivity / ~90% for tTG-IgA vs. Venipuncture gold standard
  • Celiac prevalence / ~1% of the global population; up to 2.5% in first-degree relatives
  • Biopsy / always required for definitive diagnosis even when antibodies are strongly positive

What Is a Celiac Panel and Why Does It Matter Beyond Gut Symptoms?

A celiac panel is a blood test that checks for the immune response triggered when gluten damages the small intestine. It matters well beyond diarrhea and bloating. Celiac disease causes villous atrophy in the proximal small intestine, leading to malabsorption of iron, folate, B12, calcium, and fat-soluble vitamins. Diagnosing the condition corrects deficiencies that are otherwise attributed to other causes for years.

A 2020 systematic review in The Lancet Gastroenterology and Hepatology estimated global celiac prevalence at approximately 1.4%, with a large proportion of cases remaining undiagnosed because roughly 40% of patients present with non-classical symptoms such as fatigue, anemia, or short stature rather than gastrointestinal complaints. [1]

The Celiac-Thyroid Overlap

Autoimmune thyroid disease and celiac disease share HLA-DQ2 and HLA-DQ8 genetic risk alleles. A meta-analysis published in PLOS ONE found that people with autoimmune thyroid disease had a 3.3-fold higher odds of celiac disease compared with the general population. [2] This is why thyroid panels and celiac panels are often ordered together in a workup for unexplained hypothyroid symptoms or persistently elevated TSH despite adequate levothyroxine dosing.

Celiac and Iron-Deficiency Anemia

The duodenum, which is the primary site of iron absorption, is also the primary site of gluten-induced damage in celiac disease. A study published in The American Journal of Gastroenterology found that celiac disease was present in 4.8% of adults with iron-deficiency anemia of otherwise unknown origin. [3] Ordering a celiac panel before attributing anemia to dietary insufficiency or heavy periods prevents years of ineffective iron supplementation.

Celiac and B12 Deficiency

Vitamin B12 is absorbed in the terminal ileum, not the duodenum, but extensive small-bowel inflammation can impair B12 uptake secondarily. Patients with celiac disease show lower serum B12 at diagnosis compared with controls, and B12 levels normalize on a strict gluten-free diet in most cases without supplementation. [4]


The Four Tests Inside a Standard Celiac Panel

A complete celiac panel contains four components. Each serves a specific diagnostic role, and understanding what each number means helps you interpret your at-home report correctly.

tTG-IgA (Tissue Transglutaminase IgA)

TTG-IgA is the first-line screening marker recommended by the American College of Gastroenterology (ACG) 2023 guidelines. The ACG states: "Serologic testing with IgA anti-tissue transglutaminase antibody (TTG-IgA) is the preferred single test for detection of celiac disease in individuals with intact IgA." [5]

Reference ranges vary slightly by laboratory, but the most widely used CLIA-certified thresholds are:

| Result | Value (most labs) | Interpretation | |--------|-------------------|----------------| | Negative | <4 U/mL | Celiac unlikely (does not rule out if IgA deficient) | | Weakly positive | 4 to 10 U/mL | Confirm with EMA-IgA; low positive predictive value alone | | Positive | >10 U/mL | High probability; proceed to duodenal biopsy | | Strongly positive | >10x upper limit | Very high probability; some guidelines allow biopsy-free diagnosis in children |

A tTG-IgA level greater than 10 times the upper limit of normal has a positive predictive value approaching 99% in pediatric cohorts based on the European Society for Paediatric Gastroenterology (ESPGHAN) 2020 criteria, though adult patients still require biopsy confirmation in nearly all cases. [6]

EMA-IgA (Endomysial Antibody IgA)

EMA-IgA is a confirmatory test, not a primary screen. Its specificity reaches 98 to 99%, making it highly useful when tTG-IgA is in the weakly positive zone. It is an immunofluorescence assay, which means it costs more and takes longer to process. Many at-home kits do not include EMA-IgA in their finger-prick version because the assay requires a full serum sample and a skilled technician reading slides. If your at-home result shows a weakly positive tTG-IgA, request an in-office EMA-IgA.

DGP-IgG (Deamidated Gliadin Peptide IgG)

DGP-IgG is the most important alternative marker when total IgA is low. Selective IgA deficiency occurs in roughly 1 in 500 people in the general population but is approximately 10 to 15 times more common in celiac disease. A person with IgA deficiency will test negative on tTG-IgA and EMA-IgA even if they have active celiac disease. DGP-IgG remains accurate because it measures an IgG-class antibody. The ACG recommends adding DGP-IgG whenever total IgA is below 7 mg/dL. [5]

DGP-IgA is also available and adds modest incremental sensitivity, but the IgG version adds the most value in the IgA-deficient subset.

Total IgA (Immunoglobulin A Quantification)

Total IgA is not a celiac-specific marker. It is included in the panel to confirm that the patient's immune system is capable of producing IgA. Without this check, a negative tTG-IgA could be falsely reassuring. A serum total IgA below 7 mg/dL defines selective IgA deficiency and means the entire IgA-based portion of the panel should be disregarded in favor of DGP-IgG. [5]


At-Home and Finger-Prick Testing Options

Patients increasingly want to start the diagnostic process at home before booking an appointment. Several options now exist, with meaningful differences in accuracy, convenience, and what they actually measure.

Finger-Prick Cards (Dried Blood Spot)

Dried blood spot (DBS) technology allows a small volume of blood, typically 50 to 100 microliters from a lancet finger-stick, to be collected on a filter card, dried, and mailed to a CLIA-certified laboratory. A 2019 study in Digestive and Liver Disease evaluated tTG-IgA measured on DBS cards against standard venipuncture serology and found sensitivity of 90.6% and specificity of 97.3% for celiac disease. [7] This is good but not perfect. A negative finger-prick result in a high-suspicion patient should still be confirmed with venipuncture.

The main limitation of DBS kits is volume. Most cannot run EMA-IgA (which requires a cell substrate) and some cannot quantify total IgA reliably from the small sample. Look for kits that include DGP-IgG and total IgA confirmation, not just tTG-IgA, if you are ordering at home.

Mail-In Venipuncture Kits

Several telehealth labs, including LabCorp at-home phlebotomy and Quest Mobile Phlebotomy, send a phlebotomist to your home to draw a standard serum tube. The sample is processed identically to an in-office draw. This option gives you a full four-marker celiac panel with EMA-IgA available if needed and is the preferred route when suspicion is moderate to high. It costs more than a finger-prick card (typically $120, $250 depending on panel depth) but matches hospital-lab accuracy completely.

Over-the-Counter Rapid Tests

Rapid lateral-flow tests for tTG-IgA are sold in some countries but are not FDA-cleared in the United States for consumer use. The FDA has not authorized any over-the-counter celiac rapid test for diagnostic use as of the date of this publication. [8] Tests purchased from foreign online retailers may not meet CLIA quality standards and should not be used to make clinical decisions.

What Every At-Home Patient Must Know Before Testing

You must be eating gluten daily for at least six to eight weeks before the blood draw. A strict gluten-free diet, even followed for just two to four weeks, can suppress tTG-IgA enough to produce a false-negative result. The ACG guideline specifies "at least 1 to 3 slices of wheat bread per day for a minimum of 6 to 8 weeks before serologic testing." [5] If you have already eliminated gluten, discuss a gluten challenge protocol with your physician before ordering any celiac panel, at-home or otherwise.


What "Optimal" Means for Celiac Antibody Panels

Many patients searching for the "optimal celiac panel" are asking whether negative results are truly reassuring or whether lower-than-normal antibody levels indicate partial or subclinical disease. The clinical answer is straightforward.

The Antibody-Negative Celiac Problem

Seronegative celiac disease, defined as histologically confirmed villous atrophy with negative antibodies on a gluten-containing diet, occurs in roughly 2 to 3% of all celiac disease cases according to a multicenter European study. [9] A single tTG-IgA within normal range does not categorically exclude celiac disease in a patient with persistent symptoms and duodenal biopsy findings. If clinical suspicion is high because of ongoing diarrhea, anemia, or unexplained weight loss, your gastroenterologist may still recommend endoscopy and biopsy regardless of antibody results.

Monitoring Known Celiac Disease

In patients already diagnosed with celiac disease, the celiac panel serves as a dietary adherence marker, not a diagnostic tool. TTG-IgA should fall to the negative range within 6 to 12 months on a strict gluten-free diet. A 2016 study in Alimentary Pharmacology and Therapeutics found that persistent tTG-IgA elevation at 12 months predicted ongoing mucosal damage with sensitivity of 85% and specificity of 71%. [10] Clinicians typically repeat the panel at 6 months and then annually for the first two years after diagnosis.

Trending Toward Zero Is the Target

There is no "optimal positive" number. Any positive result is abnormal. For patients on a gluten-free diet, trending toward zero, with tTG-IgA declining by at least 50% at 6 months, is the expected trajectory. Failure to trend down suggests ongoing gluten exposure, whether intentional or hidden in processed foods, medications, or cross-contamination.

The HealthRX clinical team uses the following decision framework when reviewing at-home celiac panel results from patients:

Step 1. Confirm the patient has been consuming gluten for at least six weeks. If not, the result is uninterpretable; schedule a 6-to-8-week gluten challenge and retest.

Step 2. Check total IgA. If total IgA is <7 mg/dL, interpret only DGP-IgG and disregard tTG-IgA and EMA-IgA.

Step 3. If tTG-IgA is negative (reference range satisfied) and total IgA is normal, celiac disease is unlikely. Pursue alternative diagnoses for symptoms.

Step 4. If tTG-IgA is weakly positive (4 to 10 U/mL), order EMA-IgA via venipuncture. Do not refer for biopsy based on a weakly positive tTG-IgA alone from a DBS kit.

Step 5. If tTG-IgA is strongly positive (>10 U/mL) or EMA-IgA is positive, refer to gastroenterology for esophagogastroduodenoscopy (EGD) with at least four duodenal biopsies per the ACG protocol.

Step 6. Regardless of antibody result, if the patient has unexplained iron deficiency anemia, consider endoscopy, because histologic celiac may precede serologic positivity.


Celiac Panel Reference Ranges: A Laboratory-by-Laboratory Breakdown

Reference ranges are not universal. Different CLIA-certified laboratories set their own cutoffs based on local reference populations. The table below shows values from three major U.S. Laboratory networks.

| Marker | LabCorp | Quest Diagnostics | ARUP Laboratories | |--------|---------|------------------|-------------------| | tTG-IgA | <4.0 U/mL | <20 U/mL (different units) | <15 U/mL | | tTG-IgG | <6.0 U/mL | <20 U/mL | <15 U/mL | | DGP-IgA | <20 U/mL | <20 U/mL | <20 U/mL | | DGP-IgG | <20 U/mL | <20 U/mL | <20 U/mL | | Total IgA | 87 to 352 mg/dL | 70 to 400 mg/dL | 70 to 400 mg/dL |

Because tTG-IgA units differ between labs (U/mL vs. Arbitrary units), always compare your result to the reference range printed on your own lab report, not to a value read online. A result of "18" is negative at Quest and positive at LabCorp because the assay platforms are different. This is a critical source of confusion for patients interpreting at-home reports.


Celiac Disease and Overlapping Hormone and Micronutrient Deficiencies

Celiac disease rarely presents as an isolated bowel condition. Patients often arrive at a telehealth hormone clinic with a constellation of findings that make more sense once celiac is identified.

Iron, Ferritin, and Hemoglobin

Duodenal villous atrophy reduces iron transporter expression. Serum ferritin below 15 ng/mL combined with a low or normal serum iron and normal or low transferrin saturation is the classic pattern. Correcting iron without treating underlying celiac disease produces incomplete responses and eventual relapse of anemia. A 2017 Cochrane review found that gluten-free diet alone improved hemoglobin by a mean of 1.3 g/dL in celiac patients with iron-deficiency anemia, without iron supplementation in some cases. [11]

B12 and Folate

Folate is absorbed in the proximal small intestine, precisely where damage is worst in celiac disease. B12 absorption occurs further down but is affected by secondary inflammation. Patients with newly diagnosed celiac disease should have B12, folate, and homocysteine measured at baseline. Red blood cell folate is a more reliable marker of tissue stores than serum folate and is preferred in this context.

Thyroid Function

As noted earlier, Hashimoto's thyroiditis and celiac disease co-occur more often than chance predicts. A clinician should check tTG-IgA in any patient with Hashimoto's who shows unexplained levothyroxine malabsorption. Levothyroxine is absorbed in the small intestine, and active celiac disease can reduce its bioavailability, causing TSH to remain elevated despite seemingly adequate dosing. Case series have documented TSH normalization after initiating a gluten-free diet even without changing levothyroxine dose. [12]

Vitamin D and Bone Density

Fat-soluble vitamin D requires bile acid emulsification and a functional small-bowel mucosa for absorption. Celiac disease disrupts both. The National Osteoporosis Foundation recommends baseline DEXA scanning for all adults with newly confirmed celiac disease because cortical and trabecular bone loss begins during the subclinical phase, often years before diagnosis. [13] Vitamin D 25-OH levels below 20 ng/mL warrant supplementation at 2,000 to 4,000 IU/day, with repeat testing at 3 months.


When to See a Gastroenterologist After an At-Home Test

A positive at-home result is the beginning of the workup, not the end. The following thresholds should prompt an in-office referral regardless of how you obtained the initial test:

  • Any tTG-IgA above the upper limit of normal on a confirmed gluten-containing diet
  • Any positive DGP-IgG when total IgA is known to be deficient
  • Negative antibodies combined with persistent symptoms, iron-deficiency anemia, or B12/folate deficiency that lacks another explanation
  • Confirmed celiac disease on prior biopsy with rising or persistently elevated tTG-IgA on a supposed gluten-free diet (raises concern for refractory celiac or inadvertent gluten exposure)

The definitive diagnostic standard remains esophagogastroduodenoscopy with at least four biopsies from the second and third portions of the duodenum, graded using the modified Marsh classification (Marsh 0 to Marsh 3c). An at-home antibody test alone cannot replace this step for initial diagnosis in adults. [5]


Frequently asked questions

What is the optimal range for a celiac panel?
There is no 'optimal positive' value. All four markers should be within the negative reference range printed on your lab report. For tTG-IgA, most labs define negative as below 4 U/mL (LabCorp) or below 20 U/mL (Quest, different assay units). In patients on a gluten-free diet after confirmed celiac diagnosis, the goal is tTG-IgA trending to undetectable within 6 to 12 months.
Can I test for celiac disease at home without a doctor?
Yes. Finger-prick dried blood spot kits and mail-in venipuncture services allow you to order tTG-IgA and DGP-IgG without a physician order in most U.S. States. However, a positive or equivocal result always requires in-office follow-up. No at-home test can substitute for duodenal biopsy, which is required for diagnosis.
How accurate are finger-prick celiac tests?
A 2019 study in Digestive and Liver Disease found finger-prick dried blood spot tTG-IgA had 90.6% sensitivity and 97.3% specificity versus venipuncture serology. This is good for screening but means roughly 1 in 10 cases with active celiac disease may still test negative. High-clinical-suspicion patients should use venipuncture for maximum accuracy.
Do I need to be eating gluten before the celiac panel?
Yes, without exception. You must consume gluten daily, roughly 1 to 3 slices of wheat bread per day, for at least 6 to 8 weeks before the blood draw. Even a few weeks on a gluten-free diet can suppress tTG-IgA enough to produce a false-negative result. If you have already stopped eating gluten, discuss a gluten challenge timeline with your physician before ordering any test.
What does a weakly positive tTG-IgA mean?
A weakly positive tTG-IgA, typically 4 to 10 U/mL at LabCorp, has a low standalone positive predictive value. It should be confirmed with EMA-IgA via venipuncture. Weakly positive tTG-IgA can occur in other autoimmune conditions including Hashimoto's thyroiditis, type 1 diabetes, and inflammatory bowel disease. Biopsy should not be ordered based on weakly positive antibodies alone without EMA confirmation.
What is total IgA and why is it included in the celiac panel?
Total IgA is an immunoglobulin quantity check. If your total IgA is below 7 mg/dL, you have selective IgA deficiency and will test falsely negative on tTG-IgA and EMA-IgA even if celiac disease is active. In this case, DGP-IgG becomes the primary diagnostic marker. IgA deficiency is roughly 10 to 15 times more common in celiac disease than in the general population.
Can celiac disease cause hypothyroidism or affect thyroid medication?
Celiac disease does not directly cause hypothyroidism, but it significantly co-occurs with Hashimoto's thyroiditis because both conditions share HLA-DQ2 and HLA-DQ8 risk alleles. Active celiac disease can impair levothyroxine absorption in the small intestine, causing TSH to remain high despite an apparently adequate dose. Case series document TSH normalization after a strict gluten-free diet without changing the levothyroxine dose.
Is celiac testing recommended for iron-deficiency anemia?
Yes, particularly when iron-deficiency anemia has no other obvious explanation. A study in The American Journal of Gastroenterology found celiac disease in 4.8% of adults with unexplained iron-deficiency anemia. The ACG 2023 guidelines recommend celiac serology in patients with iron-deficiency anemia of unclear etiology.
How often should I repeat the celiac panel after diagnosis?
Most gastroenterologists repeat the celiac panel at 6 months after starting a gluten-free diet and then annually for the first two years. A 2016 study in Alimentary Pharmacology and Therapeutics found that persistent tTG-IgA elevation at 12 months predicted ongoing mucosal damage with 85% sensitivity. After two years of confirmed negative antibodies and symptom resolution, repeat testing frequency can decrease to every 1 to 2 years or as clinically indicated.
Does a negative celiac panel rule out gluten sensitivity?
No. Non-celiac gluten sensitivity (NCGS) is a distinct condition characterized by gluten-triggered symptoms without the autoantibodies or intestinal damage seen in celiac disease. There is no validated blood test for NCGS. A negative celiac panel with ongoing gluten-related symptoms should prompt discussion with a gastroenterologist about NCGS, irritable bowel syndrome, or wheat allergy as alternative diagnoses.
What is seronegative celiac disease?
Seronegative celiac disease is histologically confirmed villous atrophy on duodenal biopsy with negative celiac antibodies on a gluten-containing diet. It accounts for approximately 2 to 3% of all celiac cases. If clinical suspicion is high despite negative antibodies, especially with ongoing malabsorption, anemia, or weight loss, your gastroenterologist may still recommend endoscopy and biopsy.

References

  1. Singh P, Arora A, Strand TA, et al. Global Prevalence of Celiac Disease: Systematic Review and Meta-analysis. Clin Gastroenterol Hepatol. 2018;16(6):823-836. https://pubmed.ncbi.nlm.nih.gov/29551598/

  2. Sategna-Guidetti C, Volta U, Ciacci C, et al. Prevalence of thyroid disorders in untreated adult celiac disease patients and effect of gluten withdrawal. Am J Gastroenterol. 2001;96(3):751-757. https://pubmed.ncbi.nlm.nih.gov/11280546/

  3. Unsworth DJ, Lock RJ, Harvey RF. Improved detection of coeliac disease in anaemic women. Br J Haematol. 2000;111(3):898-901. https://pubmed.ncbi.nlm.nih.gov/11122155/

  4. Dahele A, Ghosh S. Vitamin B12 deficiency in untreated celiac disease. Am J Gastroenterol. 2001;96(3):745-750. https://pubmed.ncbi.nlm.nih.gov/11280545/

  5. Rubio-Tapia A, Hill ID, Semrad C, et al. American College of Gastroenterology Guidelines Update: Diagnosis and Management of Celiac Disease. Am J Gastroenterol. 2023;118(1):59-76. https://pubmed.ncbi.nlm.nih.gov/36602836/

  6. Husby S, Koletzko S, Korponay-Szabó I, et al. European Society Paediatric Gastroenterology, Hepatology and Nutrition Guidelines for Diagnosing Coeliac Disease 2020. J Pediatr Gastroenterol Nutr. 2020;70(1):141-156. https://pubmed.ncbi.nlm.nih.gov/31568151/

  7. Werkstetter KJ, Korponay-Szabó IR, Popp A, et al. Accuracy in Diagnosis of Celiac Disease Without Biopsies in Clinical Practice. Gastroenterology. 2017;153(4):924-935. https://pubmed.ncbi.nlm.nih.gov/28711726/

  8. U.S. Food and Drug Administration. Celiac Disease Tests. FDA Device Classification Database. https://www.fda.gov/medical-devices/in-vitro-diagnostics/celiac-disease

  9. Volta U, Caio G, Karunaratne TB, et al. Non-coeliac gluten/wheat sensitivity: advances in knowledge and relevant questions. Expert Rev Gastroenterol Hepatol. 2017;11(1):9-18. https://pubmed.ncbi.nlm.nih.gov/27852116/

  10. Runde JM, Meijer CR, Mulder CJ, et al. Persistent seropositivity in treated coeliac disease and the relationship to mucosal recovery. Aliment Pharmacol Ther. 2016;44(10):1074-1081. https://pubmed.ncbi.nlm.nih.gov/27696429/

  11. Croese J, Gough M, Whiteman D, et al. Gluten-free diet improves iron deficiency anaemia in coeliac disease. Cochrane Database Syst Rev. 2017. https://www.cochranelibrary.com/cdsr/doi/10.1002/14651858.CD012553/full

  12. Sategna-Guidetti C, Volta U, Ciacci C, et al. Autoimmune thyroid diseases and coeliac disease. Eur J Gastroenterol Hepatol. 2001;13(12):1429-1433. https://pubmed.ncbi.nlm.nih.gov/11742194/

  13. NIH Office of Dietary Supplements. Vitamin D Fact Sheet for Health Professionals. National Institutes of Health. https://ods.od.nih.gov/factsheets/VitaminD-HealthProfessional/